Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Neuroendocrine carcinoma of the esophagus with an adenocarcinoma component.

Kaneko Y, Saito S, Takahashi K, Kanamaru R, Hosoya Y, Yamaguchi H, Kitayama J, Niki T, Lefor AK, Sata N.

Clin J Gastroenterol. 2019 May 27. doi: 10.1007/s12328-019-00995-7. [Epub ahead of print]

PMID:
31134449
2.

Neutrophil Extracellular Traps Generated by Low Density Neutrophils Obtained from Peritoneal Lavage Fluid Mediate Tumor Cell Growth and Attachment.

Kanamaru R, Ohzawa H, Miyato H, Yamaguchi H, Hosoya Y, Lefor AK, Sata N, Kitayama J.

J Vis Exp. 2018 Aug 3;(138). doi: 10.3791/58201.

PMID:
30124642
3.

Low density neutrophils (LDN) in postoperative abdominal cavity assist the peritoneal recurrence through the production of neutrophil extracellular traps (NETs).

Kanamaru R, Ohzawa H, Miyato H, Matsumoto S, Haruta H, Kurashina K, Saito S, Hosoya Y, Yamaguchi H, Yamashita H, Seto Y, Lefor AK, Sata N, Kitayama J.

Sci Rep. 2018 Jan 12;8(1):632. doi: 10.1038/s41598-017-19091-2.

4.

Boerhaave's syndrome in a patient with an upside down stomach: A case report.

Saito S, Hosoya Y, Kurashina K, Matsumoto S, Kanamaru R, Ui T, Haruta H, Kitayama J, Lefor AK, Sata N.

Int J Surg Case Rep. 2016;19:51-4. doi: 10.1016/j.ijscr.2015.12.016. Epub 2015 Dec 17.

5.

Hepatic portal venous gas after endoscopy in a patient with anastomotic obstruction.

Sadatomo A, Koinuma K, Kanamaru R, Miyakura Y, Horie H, Lefor AT, Yasuda Y.

World J Gastrointest Surg. 2015 Feb 27;7(2):21-4. doi: 10.4240/wjgs.v7.i2.21.

6.

Phase I study of irinotecan by 24-h intravenous infusion in combination with 5-fluorouracil in metastatic colorectal cancer.

Kambe M, Kikuchi H, Gamo M, Yoshioka T, Ohashi Y, Kanamaru R.

Int J Clin Oncol. 2012 Apr;17(2):150-4. doi: 10.1007/s10147-011-0272-9. Epub 2011 Jul 26.

PMID:
21786211
7.

Two-dimensional visualization of cholesterol and cholesteryl esters within human coronary plaques by near-infrared fluorescence angioscopy.

Uchida Y, Uchida Y, Sugiyama Y, Tomaru T, Kawai S, Kanamaru R, Shimoyama E.

Clin Cardiol. 2010 Dec;33(12):775-82. doi: 10.1002/clc.20780.

8.

Detection of vulnerable coronary plaques by color fluorescent angioscopy.

Uchida Y, Uchida Y, Kawai S, Kanamaru R, Sugiyama Y, Tomaru T, Maezawa Y, Kameda N.

JACC Cardiovasc Imaging. 2010 Apr;3(4):398-408. doi: 10.1016/j.jcmg.2009.09.030.

9.

Imaging of lysophosphatidylcholine in human coronary plaques by color fluorescence angioscopy.

Uchida Y, Uchida Y, Kawai S, Kanamaru R, Kameda N.

Int Heart J. 2010 Mar;51(2):129-33.

10.

Second-harmonic-generation microscope using eight-segment polarization-mode converter to observe three-dimensional molecular orientation.

Yoshiki K, Kanamaru R, Hashimoto M, Hashimoto N, Araki T.

Opt Lett. 2007 Jun 15;32(12):1680-2. Erratum in: Opt Lett. 2007 Aug 15;32(16):2465. Ryosuke, Kanamaru [corrected to Kanamaru, Ryosuke].

PMID:
17572745
11.

FDG PET and gallium scintigraphy for diagnosis of an advanced jejunal adenocarcinoma with distant metastases.

Yamaura G, Yoshioka T, Kubota K, Yamaguchi K, Iwata R, Abe T, Kitagawa Y, Kanamaru R, Fukuda H, Ishioka C.

Clin Nucl Med. 2004 Dec;29(12):825-7. No abstract available.

PMID:
15545894
12.

Activation mechanism of c-Jun amino-terminal kinase in the course of neural differentiation of P19 embryonic carcinoma cells.

Akiyama S, Yonezawa T, Kudo TA, Li MG, Wang H, Ito M, Yoshioka K, Ninomiya-Tsuji J, Matsumoto K, Kanamaru R, Tamura S, Kobayashi T.

J Biol Chem. 2004 Aug 27;279(35):36616-20. Epub 2004 Jun 24.

13.

PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma.

Kato H, Fujimura M, Kumabe T, Ishioka C, Kanamaru R, Yoshimoto T.

J Clin Neurosci. 2004 Jan;11(1):37-41.

PMID:
14642363
14.

Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library.

Shiraishi K, Kato S, Han SY, Liu W, Otsuka K, Sakayori M, Ishida T, Takeda M, Kanamaru R, Ohuchi N, Ishioka C.

J Biol Chem. 2004 Jan 2;279(1):348-55. Epub 2003 Oct 13.

15.

Biweekly administration regimen of docetaxel combined with CPT-11 in patients with inoperable or recurrent gastric cancer.

Yoshioka T, Sakata Y, Terashima M, Sekikawa K, Gamoh M, Mitachi Y, Saitoh S, Kanamaru R.

Gastric Cancer. 2003;6(3):153-8.

PMID:
14520528
16.

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.

Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, Ishioka C.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9. Epub 2003 Jun 25.

17.

Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer.

Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, Yamaura G, Takahashi H, Fukuda H, Kanamaru R.

J Nucl Med. 2003 May;44(5):690-9.

18.

Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2genes in familial breast cancer.

Sakayori M, Kawahara M, Shiraishi K, Nomizu T, Shimada A, Kudo T, Abe R, Ohuchi N, Takenoshita S, Kanamaru R, Ishioka C.

J Hum Genet. 2003;48(3):130-7.

PMID:
12624724
19.

Analysis of the human APC mutation spectrum in a saccharomyces cerevisiae strain with a mismatch repair defect.

Otsuka K, Suzuki T, Shibata H, Kato S, Sakayori M, Shimodaira H, Kanamaru R, Ishioka C.

Int J Cancer. 2003 Feb 20;103(5):624-30.

20.

Alpha-FP normalization as a prognostic factor for mediastinal origin embryonal carcinoma: report of five cases.

Murakawa Y, Satake N, Kato S, Yosioka T, Kanamaru R.

Intern Med. 2002 Oct;41(10):883-8.

21.

Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer.

Yamaguchi K, Tada M, Horikoshi N, Otani T, Takiuchi H, Saitoh S, Kanamaru R, Kasai Y, Koizumi W, Sakata Y, Taguchi T; Paclitaxel Gastric Cancer Study Group in Japan.

Gastric Cancer. 2002;5(2):90-5.

PMID:
12111584
22.

Phase I studies of nogitecan hydrochloride for Japanese.

Kobayashi K, Hino M, Fukuoka M, Takeuchi K, Furuse K, Yoneda S, Hasegawa K, Noda K, Kinoshita H, Kimura I, Taguchi T, Kanamaru R, Horikoshi N, Niitani H.

Int J Clin Oncol. 2002 Jun;7(3):177-86.

PMID:
12109520
23.

Regulation of the TAK1 signaling pathway by protein phosphatase 2C.

Hanada M, Ninomiya-Tsuji J, Komaki K, Ohnishi M, Katsura K, Kanamaru R, Matsumoto K, Tamura S.

J Biol Chem. 2001 Feb 23;276(8):5753-9. Epub 2000 Dec 4.

24.

Functional evaluation of p53 and PTEN gene mutations in gliomas.

Kato H, Kato S, Kumabe T, Sonoda Y, Yoshimoto T, Kato S, Han SY, Suzuki T, Shibata H, Kanamaru R, Ishioka C.

Clin Cancer Res. 2000 Oct;6(10):3937-43.

25.

[Cancer diagnosis using microarray technologies].

Kanamaru R.

Gan To Kagaku Ryoho. 2000 Jul;27(7):949-53. Review. Japanese.

PMID:
10925677
26.

Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.

Han SY, Kato H, Kato S, Suzuki T, Shibata H, Ishii S, Shiiba K, Matsuno S, Kanamaru R, Ishioka C.

Cancer Res. 2000 Jun 15;60(12):3147-51.

27.

Osteomalacia that became symptomatic 13 years after a total gastrectomy.

Kikuchi H, Ujiie S, Kanamaru R.

Intern Med. 2000 May;39(5):394-6.

28.

The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region.

Mukouyama Y, Chiba N, Hara T, Okada H, Ito Y, Kanamaru R, Miyajima A, Satake M, Watanabe T.

Dev Biol. 2000 Apr 1;220(1):27-36.

29.

Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.

Kato S, Shimada A, Osada M, Ikawa S, Obinata M, Nakagawara A, Kanamaru R, Ishioka C.

Cancer Res. 1999 Dec 1;59(23):5908-11.

30.

[Genetic background in carcinogenesis].

Suzuki T, Kanamaru R.

Gan To Kagaku Ryoho. 1999 Nov;26(13):1971-9. Review. Japanese.

PMID:
10584560
31.

A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers.

Yoshioka T, Gamoh M, Shineha R, Ishibashi S, Shibata H, Suzuki T, Murakawa Y, Kato S, Shimodaira H, Kato S, Ishioka C, Kanamaru R.

Intern Med. 1999 Nov;38(11):844-8.

32.

FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy.

Yoshioka T, Fukuda H, Fujiwara T, Iwata R, Ido T, Murakawa Y, Gamo M, Ishioka C, Kanamaru R.

Clin Nucl Med. 1999 Apr;24(4):261-3.

PMID:
10466523
33.

[Advances in cancer research. Cancer research and clinical oncology in the 21st century].

Kanamaru R.

Gan To Kagaku Ryoho. 1999 Jun;26 Suppl 1:3-7. Review. Japanese.

PMID:
10410653
34.

Influence of p53 mutation on pathological grade, but not prognosis of non-Hodgkin's lymphoma.

Osada M, Ishioka C, Ichinohasama R, Kadowaki I, Murakawa Y, Watanabe M, Kanamaru R, Ikawa S.

Anticancer Drug Des. 1999 Apr;14(2):107-14.

PMID:
10405637
35.

The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.

Shimada A, Kato S, Enjo K, Osada M, Ikawa Y, Kohno K, Obinata M, Kanamaru R, Ikawa S, Ishioka C.

Cancer Res. 1999 Jun 15;59(12):2781-6.

36.

Sclerosing mediastinitis: findings on fluorine-18 fluorodeoxyglucose positron emission tomography.

Imran MB, Kubota K, Yoshioka S, Yamada S, Sato T, Fukuda H, Yoshioka T, Kanamaru R, Fujiwara T, Itoh M.

Clin Nucl Med. 1999 May;24(5):305-8.

PMID:
10232465
37.

[A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].

Mai M, Sakata Y, Kanamaru R, Kurihara M, Suminaga M, Ota J, Hirabayashi N, Taguchi T, Furue H.

Gan To Kagaku Ryoho. 1999 Mar;26(4):487-96. Japanese.

PMID:
10097745
38.

[Genetic diagnosis of familial colorectal tumor by using a budding yeast cells].

Kanamaru R, Suzuki T.

Nihon Shokakibyo Gakkai Zasshi. 1999 Feb;96(2):131-6. Japanese. No abstract available.

PMID:
10087883
39.

Astrocytoma and B-cell lymphoma development in a man with a p53 germline mutation.

Murakawa Y, Yokoyama A, Kato S, Yoshioka T, Ichinohasama R, Kumabe T, Yoshimoto T, Ishioka C, Kanamaru R.

Jpn J Clin Oncol. 1998 Oct;28(10):631-7.

PMID:
9839505
40.

[Phase I study of raltitrexed (ZD-1694)].

Horikoshi N, Aiba K, Fukuoka M, Akazawa S, Sakata Y, Furuse K, Kanamaru R, Kudoh S, Konishi T, Kurihara M, Niitani H, Furue H, Tsukagoshi S, Taguchi T, Yoshida S, Ota K, Kotake T, Wakui A.

Gan To Kagaku Ryoho. 1998 Nov;25(13):2075-84. Japanese.

PMID:
9838910
41.

Selective suppression of stress-activated protein kinase pathway by protein phosphatase 2C in mammalian cells.

Hanada M, Kobayashi T, Ohnishi M, Ikeda S, Wang H, Katsura K, Yanagawa Y, Hiraga A, Kanamaru R, Tamura S.

FEBS Lett. 1998 Oct 23;437(3):172-6.

42.

[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)].

Taguchi T, Sakata Y, Kanamaru R, Kurihara M, Suminaga M, Ota J, Hirabayashi N.

Gan To Kagaku Ryoho. 1998 Oct;25(12):1915-24. Japanese.

PMID:
9797814
43.
44.

[Rapid growth of glioblastoma during therapy for multiple myeloma: case report].

Sonoda Y, Kumabe T, Umezawa K, Shimizu H, Murakawa Y, Kanamaru R, Yoshimoto T.

No Shinkei Geka. 1998 Aug;26(8):737-41. Japanese.

PMID:
9744004
45.
46.

An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer.

Ohtsu A, Boku N, Tamura F, Muro K, Shimada Y, Saigenji K, Akazawa S, Kitajima M, Kanamaru R, Taguchi T.

Am J Clin Oncol. 1998 Aug;21(4):416-9.

PMID:
9708646
47.

Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae.

Shimodaira H, Filosi N, Shibata H, Suzuki T, Radice P, Kanamaru R, Friend SH, Kolodner RD, Ishioka C.

Nat Genet. 1998 Aug;19(4):384-9. Erratum in: Nat Genet 1999 Feb;21(2):241.

PMID:
9697702
48.

Cloning and functional analysis of human p51, which structurally and functionally resembles p53.

Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M, Ikawa S.

Nat Med. 1998 Jul;4(7):839-43. Erratum in: Nat Med 1998 Sep;4(9):982.

PMID:
9662378
49.

Detection of APC mutations by a yeast-based protein truncation test (YPTT).

Suzuki T, Ishioka C, Kato S, Mitachi Y, Shimodaira H, Sakayori M, Shimada A, Asamura M, Kanamaru R.

Genes Chromosomes Cancer. 1998 Apr;21(4):290-7.

PMID:
9559340
50.

[Phase I study of orally administered UFT plus l-leucovorin].

Horikoshi N, Aiba K, Kanamaru R, Hasegawa K, Takeda S, Taguchi T, Niitani H, Furue H, Kurihara M, Ogawa M, Abe T.

Gan To Kagaku Ryoho. 1998 Mar;25(4):531-9. Japanese.

PMID:
9530359

Supplemental Content

Loading ...
Support Center